Alan B Brown

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Molecular Docking

Advanced Non Small Cell Lung Cancer

Silver Nanoparticles

Top Venues

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Lamya H Al-Wahaibi, Bahaa G M Youssif, Hesham A Abou-Zied, Stefan Bräse, Alan B Brown, Hendawy N Tawfeek, Essmat M El-Sheref
Synthesis of a new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAF V600E inhibitors. RSC medicinal chemistry 15 (7) (2024)
Lamya H Al-Wahaibi, Bahaa G M Youssif, Hesham A Abou-Zied, Stefan Bräse, Alan B Brown, Hendawy N Tawfeek, Essmat M El-Sheref
Synthesis of a new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAF V600E inhibitors. RSC medicinal chemistry 15 (7) (2024)
Asmaa H Mohamed, Sara M Mostafa, Ashraf A Aly, Alaa A Hassan, Esraa M Osman, AbdElAziz A Nayl, Alan B Brown, El Shimaa M N Abdelhafez
Novel quinoline/thiazinan-4-one hybrids; design, synthesis, and molecular docking studies as potential anti-bacterial candidates against MRSA. RSC advances 13 (21) (2023)
Mohammed B Alshammari, Ashraf A Aly, Akil Ahmad, Alan B Brown, Asmaa H Mohamed
Recent synthetic strategies of spiro-azetidin-2-one, -pyrrolidine, -indol(one) and -pyran derivatives-a review. RSC advances 13 (46) (2023)
Asmaa H Mohamed, Sara M Mostafa, Ashraf A Aly, Alaa A Hassan, Esraa M Osman, AbdElAziz A Nayl, Alan B Brown, El Shimaa M N Abdelhafez
Novel quinoline/thiazinan-4-one hybrids; design, synthesis, and molecular docking studies as potential anti-bacterial candidates against MRSA. RSC advances 13 (21) (2023)